Together with RG Discovery, we provide fragment screening services using our proprietary weak-affinity chromatography (WAC™) technology. After seven years of rigorous testing, WAC™ has clearly demonstrated its cost-effectiveness as a high-throughput method for generating exceptional starting points for hit-to-lead Medicinal Chemistry programs, thereby advancing clients’ projects.
